Leadless LAA Pacemaker for Thrombus Prevention and AF Monitoring
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cardiac ablation procedures for atrial fibrillation face challenges in effectively isolating the left atrial appendage (LAA) due to its varying morphologies and sizes, leading to increased risk of thromboembolic events and inadequate function, which existing devices fail to address adequately.
Innovation Solution
A leadless pacemaker system designed for implantation within the LAA, capable of monitoring AF episodes, delivering ATP pulses, and achieving electrical isolation while preventing thrombus formation, utilizing a device that takes shape after deployment and includes materials for endothelialization and visualization aids like electrodes for optimal placement.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If LAA isolation is performed during ablation procedures, then atrial fibrillation treatment is improved, but the risk of thromboembolic events increases
Solution Approach 1:
The device performs preliminary action by delivering anti-tachycardia pacing (ATP) pulses and pacing therapy before thrombus formation can occur, maintaining LAA function and preventing stasis. The device is implanted prior to isolation to ensure continuous monitoring and active prevention of thrombus formation throughout the isolation process and beyond.
Solution Approach 2:
The device enables self-service by autonomously monitoring LAA electrical activity, detecting arrhythmias, and delivering appropriate pacing therapy without requiring external intervention. The implanted device continuously assesses LAA function and automatically responds to abnormal rhythms, ensuring ongoing prevention of thrombus formation independent of external medical intervention.
2Adaptability or versatility
If ablation tools are used to accommodate various LAA morphologies, then adaptability is improved, but device complexity increases
Solution Approach 1:
The device achieves universality by being implantable within the LAA itself rather than requiring external catheters or tools that must adapt to different LAA geometries. The leadless pacemaker design allows it to function within various LAA morphologies (windsock, chicken-wing, etc.) without requiring complex external manipulation tools, as the device adapts to the LAA space where it is implanted.
Solution Approach 2:
The device acts as an intermediary by being implanted directly within the LAA to provide internal monitoring and pacing, eliminating the need for complex external ablation tools that must navigate and adapt to different LAA morphologies. The implanted device serves as a permanent mediator that continuously interfaces with LAA tissue regardless of its specific shape or structure.
3Reliability
If electrical isolation of LAA is achieved, then AF burden is reduced, but LAA squeezing function becomes inadequate
Solution Approach 1:
The device performs preliminary action by delivering anti-tachycardia pacing (ATP) pulses before complete electrical isolation occurs, maintaining LAA contractility and squeezing function throughout the isolation process. By providing pacing therapy during the transition to isolation, the device prevents the development of inadequate LAA function that would otherwise occur after isolation.
Solution Approach 2:
The device ensures continuity of useful action by maintaining continuous pacing and monitoring of LAA electrical activity even after electrical isolation is achieved. The implanted device continuously delivers pacing pulses to maintain LAA contractility and squeezing function, ensuring that the useful action of LAA blood propulsion continues uninterrupted despite electrical isolation from the rest of the atrium.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Apparatus, systems, and methods are provided for monitoring AF episodes, delivering ATP pulses, and/or achieving electrical isolation of the left atrial appendage (LAA) of a patient's heart and/or preventing thrombus formation after electrical isolation. For example, devices are provided that may implanted from within the left atrium, e.g., to isolate the LAA, prevent thrombus formation within the LAA, facilitate endothelialization, and/or deliver pacing.